SCHEMBL24211812

SCHEMBL24211812

O=C(Cn1cc(S(=O)(=O)N2CCCCC2)ccc1=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ AGTR1 P30556 2/20 0.49
▸ LMNA P02545 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ TP53 P04637 2/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ GAA P10253 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ IL1RN P18510 1/20 0.47
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18038978 0.99 L3MBTL1 (0.54) L3MBTL1POLBAGTR1LMNAKDM4E
SCHEMBL18038954 0.92 L3MBTL1 (0.56) L3MBTL1POLBAGTR1LMNAKDM4E
SCHEMBL18038989 0.92 L3MBTL1 (0.56) L3MBTL1POLBAGTR1LMNAKDM4E
SCHEMBL18038959 0.92 L3MBTL1 (0.56) L3MBTL1POLBAGTR1LMNAKDM4E
SCHEMBL18038953 0.89 L3MBTL1 (0.53) L3MBTL1POLBAGTR1LMNAKDM4E
SCHEMBL18038943 0.89 L3MBTL1 (0.53) L3MBTL1POLBLMNACYP1A2GAA
SCHEMBL18038951 0.88 L3MBTL1 (0.52) L3MBTL1POLBLMNACYP1A2GAA
SCHEMBL18038990 0.88 L3MBTL1 (0.52) L3MBTL1POLBLMNACYP1A2GAA
SCHEMBL18038979 0.88 L3MBTL1 (0.52) L3MBTL1POLBLMNACYP1A2GAA
SCHEMBL18038965 0.88 L3MBTL1 (0.52) L3MBTL1POLBAGTR1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017486-A1 DOCK1-INHIBITING COMPOUND AND USE THEREOF KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017486-A1 DOCK1-INHIBITING COMPOUND AND USE THEREOF DOCK2, DOCK11, DOCK5 L3MBTL1 69/4885POLB 3893/4885AGTR1 658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback